CHINA PHARMA HOLDINGS, INC. Stock Issued During Period, Shares, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, shares, conversion of units for the quarter ending 2022-12-31 was -31.14M shares.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, shares, conversion of units for the quarter ending 2022-09-30 was 9.88M shares.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, shares, conversion of units for the quarter ending 2022-06-30 was 8.89M shares.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, shares, conversion of units for the quarter ending 2022-03-31 was 12.49M shares.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, shares, conversion of units for fiscal 2022 was 126.67K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 3 month | Stock Issued During Period, Shares, Conversion of Units 12 month |
|---|---|---|
| 2022-12-31 | -31.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 126.67K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 9.88M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2022-06-30 | 8.89M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 12.49M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 11.98M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |